In the latest bid to pull back the curtain on pharmacy benefit managers, the Louisiana Attorney General filed a lawsuit accusing OptumRx of inflating the price of prescription drugs that cost the state Medicaid program billions of dollars.
The lawsuit alleges that OptumRx, which is one of the largest pharmacy benefit managers, and its corporate parent, UnitedHealth Group, used a series of opaque tactics that ultimately caused the state to be overcharged for medicines. The companies also refused to provide requested documents and data, according to the lawsuit, which was filed in a Louisiana state court.
The companies “exploit(ed) the secrecy that surrounds the real prices paid for prescription drugs through the supply chain, as well as the complex system of rebates, reimbursements and other payments that cause health insurers — like the Louisiana Medicaid program — to needlessly pay billions of dollars more per year for prescription drugs than they otherwise would pay,” the state charged.
Create a display name to comment
This name will appear with your comment